Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tempest Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Tempest Therapeutics

Tempest Therapeutics

Acquired

Tempest Therapeutics: A global biotech firm developing targeted, immune-mediated anti-tumor therapies.

HQ
South San Francisco, CA, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Tempest Therapeutics, founded with a core mission to develop innovative cancer therapies, focuses on modulating anti-tumor immunity pathways. The company is dedicated to creating first-in-class oral drug therapeutics with broad potential benefits for cancer patients. By exploring both new and validated pathways, Tempest aims to discover and develop novel treatments that can significantly impact the global fight against cancer.

Notable figures affiliated with Tempest Therapeutics include experienced leaders in biotechnology and oncology. The company has attracted significant investment from leading venture capital firms, which has enabled it to advance its research and development efforts. Key achievements include the successful progression of its drug candidates through various stages of clinical trials, demonstrating promising results. Overall, Tempest Therapeutics is making a substantial impact in the field of cancer treatment, offering hope to patients worldwide through its pioneering therapies.

Tempest Therapeutics - Similar Companies

PineTree Therapeutics logo

PineTree Therapeutics

pinetreetx.com

Terpenoid Therapeutics logo

Terpenoid Therapeutics

Window Therapeutics logo

Window Therapeutics

windowtx.com

Fuse Biotherapeutics logo

Fuse Biotherapeutics

fusebiotx.com

Thetis Pharmaceuticals logo

Thetis Pharmaceuticals

thetispharma.com

Nimbus Therapeutics logo

Nimbus Therapeutics

nimbustx.com

Tango Therapeutics logo

Tango Therapeutics

tangotx.com

Tizona Therapeutics logo

Tizona Therapeutics

tizonatx.com

LTZ Therapeutics logo

LTZ Therapeutics

Checkpoint Therapeutics logo

Checkpoint Therapeutics

checkpointtx.com

Vivace Therapeutics logo

Vivace Therapeutics

Angarus Therapeutics logo

Angarus Therapeutics

angarustx.com

Telo Therapeutics logo

Telo Therapeutics

Palm Therapeutics logo

Palm Therapeutics

Meditope Biosciences logo

Meditope Biosciences

meditope.com

Tempest Therapeutics - Quick Facts

Who are Tempest Therapeutics' competitors?

Companies similar to Tempest Therapeutics include PineTree Therapeutics, Terpenoid Therapeutics, Window Therapeutics and Fuse Biotherapeutics.

When was Tempest Therapeutics founded?

Tempest Therapeutics was founded in 2011.

Where is Tempest Therapeutics' headquarters located?

Tempest Therapeutics' headquarters is located in South San Francisco, CA, US.

When was Tempest Therapeutics' last funding round?

Tempest Therapeutics' most recent funding round was for $15M (USD) in April 2022.

How much has Tempest Therapeutics raised to-date?

As of Apr 27, 2022, Tempest Therapeutics has raised a total of $90M (USD).

Tempest Therapeutics - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Biotech
  • Healthcare
Unique IDs
  • ein: 451472564
  • secCik: 0001544227
  • ticker: TPST
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325413In-Vitro Diagnostic Substance Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2835In Vitro And In Vivo Diagnostic Substances
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research